Lene Dissing Sjö

Lene Dissing Sjö

Clinical Associate Professor

Member of:

  • Pathology


  1. Published

    TP53 hotspot mutations are predictive of survival in primary central nervous system lymphoma patients treated with combination chemotherapy

    Munch-Petersen, H. D., Asmar, F., Dimopoulos, K., Areškevičiūtė, A., Brown, Peter de Nully, Girkov, M. S., Pedersen, A., Sjö, Lene Dissing, Heegaard, Steffen, Broholm, H., Kristensen, L. S., Ralfkiaer, E. & Grønbæk, Kirsten, 22 Apr 2016, In: Acta Neuropathologica Communications. 4, 13 p., 40.

    Research output: Contribution to journalJournal articleResearch

  2. Published

    A predictive model for bone marrow disease in cytopenia based on noninvasive procedures

    Træden, D., Tulstrup, M., Cowland, J. B., Sjö, Lene Dissing, Bøgsted, M., Grønbæk, Kirsten, Andersen, M. K. & Hansen, J. W., 2022, In: Blood advances. 6, 11, p. 3541-3550

    Research output: Contribution to journalJournal articleResearchpeer-review

  3. Published

    Atypisk præsentation af penilt blue naevus

    Gotland, N., Bandier, J., Karmisholt, Katrine Elisabeth, Sjö, Lene Dissing & Venzo, A., 2020, In: Ugeskrift for Laeger. 182, 40, 3 p., V03200163.

    Research output: Contribution to journalJournal articleResearchpeer-review

  4. Published

    Blastic plasmacytoid dendritic cell neoplasm and cerebral toxoplasmosis: a case report

    Florescu, A. M., Sørensen, A. L. T., Nielsen, H. V., Tolnai, D., Sjö, Lene Dissing, Larsen, K. L. & Al-Karagholi, M. A., 2022, In: BMC Neurology. 22, 6 p., 233.

    Research output: Contribution to journalJournal articleResearchpeer-review

  5. Published

    Clinicopathological Features of Ocular Adnexal Mantle-Cell Lymphoma in an International Multicenter Cohort

    Knudsen, M. K. H., Rasmussen, P. K., Coupland, S. E., Esmaeli, B., Finger, P. T., Graue, G. F., Grossniklaus, H. E., Khong, J. J., McKelvie, P. A., Mulay, K., Ralfkiaer, E., Sjö, Lene Dissing, Vemuganti, G. K., Thuro, B. A., Curtin, J. & Heegaard, Steffen, 2017, In: JAMA Ophthalmology. 135, 12, p. 1367-1374 8 p.

    Research output: Contribution to journalJournal articleResearchpeer-review

  6. Published

    Combining epigenetic therapy with venetoclax overcomes alemtuzumab resistance in T-cell prolymphocytic leukemia: A case report of a 26-year-old man with a prior history of T-cell acute lymphoblastic leukemia and GI-T lymphoma

    Andersen, M. A., Valentin, R., Sjö, Lene Dissing, Borgwardt, L., Schmiegelow, Kjeld, Andersen, M. K., Marvig, R. L., Yde, C. W. & Niemann, Carsten, 2020, In: Acta Oncologica. 59, 12, p. 1547-1551

    Research output: Contribution to journalComment/debateResearchpeer-review

  7. Published

    Conjunctival Lymphoma: An International Multicenter Retrospective Study

    Kirkegaard, M. M., Rasmussen, P. K., Coupland, S. E., Esmaeli, B., Finger, P. T., Graue, G. F., Grossniklaus, H. E., Honavar, S. G., Khong, J. J., McKelvie, P. A., Mulay, K., Prause, J. U., Ralfkiaer, E., Sjö, Lene Dissing, Toft, Peter Bjerre, Vemuganti, G. K., Thuro, B. A., Curtin, J. & Heegaard, Steffen, Apr 2016, In: J A M A Ophthalmology. 134, 4, p. 406-14 9 p.

    Research output: Contribution to journalJournal articleResearchpeer-review

  8. Published

    Differential Expression of miR-155 and miR-21 in Tumor and Stroma Cells in Diffuse Large B-Cell Lymphoma

    Munch-Petersen, H. D., Ralfkiaer, U., Sjö, Lene Dissing, Hother, C., Asmar, F., Nielsen, B. S., Brown, P., Ralfkiaer, E. & Grønbæk, Kirsten, Mar 2015, In: Applied Immunohistochemistry & Molecular Morphology. 23, 3, p. 188-195 8 p.

    Research output: Contribution to journalJournal articleResearchpeer-review

  9. Published

    Diffuse large B-cell lymphoma of the ocular adnexal region: A nation-based study

    Rasmussen, P. K., Ralfkiaer, E., Prause, J. U., Sjö, Lene Dissing, Toft, Peter Bjerre, Siersma, Volkert Dirk & Heegaard, Steffen, 2013, In: Acta Ophthalmologica. 91, p. 163-169 7 p.

    Research output: Contribution to journalJournal articleResearchpeer-review

  10. Published

    Dual inhibition of DNMTs and EZH2 can overcome both intrinsic and acquired resistance of myeloma cells to IMiDs in a cereblon-independent manner

    Dimopoulos, K., Søgaard Helbo, A., Fibiger Munch-Petersen, H., Sjö, Lene Dissing, Christensen, J., Sommer Kristensen, L., Asmar, F., Hermansen, N. E. U., O'Connel, C., Gimsing, P., Liang, G. & Grønbæk, Kirsten, Feb 2018, In: Molecular Oncology. 12, 2, p. 180-195

    Research output: Contribution to journalJournal articleResearchpeer-review

Previous 1 2 3 4 Next

ID: 6945